Prostate Active Surveillance Study

Summary

The Prostate Active Surveillance Study (PASS) is a research study for men who have chosen active surveillance as a management plan for their prostate cancer. Active surveillance is defined as close monitoring of prostate cancer with the offer of treatment if there are changes in test results. This study seeks to discover markers that will identify cancers that are more aggressive from those tumors that grow slowly.

Conditions

• Prostatic Neoplasms

Sponsors & Collaborators

• Canary Foundation

  collaborator OTHER

• Early Detection Research Network

  collaborator NETWORK

• University of Washington

  lead OTHER

Principal Investigators

• Daniel W. Lin, MD · University of Washington

• James D. Brooks, MD · Stanford University

• Martin E. Gleave, MD · University of British Columbia

• Michael Liss, MD · University of Texas Health Science Center San Antonio

• Peter R. Carroll, MD, MPH · University of California, San Francisco

• Robert W. Given, MD · Eastern Virginia Medical School

• Andrew A Wagner, MD · Beth Israel Deaconess Medical Center/Harvard Medical School

• Todd M. Morgan, MD · University of Michigan

• Lisa F Newcomb, PhD · Fred Hutchinson Cancer Research Center/University of Washington

• Martin G. Sanda, MD · Emory University

• Matthew R. Cooperberg, MD, MPH · Veterans Affairs San Francisco Health Care System

• Atreya Dash, MD · Veterans Affairs Puget Sound Health Care System

Eligibility

Min Age

21 Years

Sex

MALE

Healthy Volunteers

No

Timeline & Regulatory

Start

2008-07-31

Primary Completion

2029-09-30

Completion

2032-09-30

Countries

• United States
• Canada

Study Locations